Brief Articles
Copyright ©2009 The WJG Press and Baishideng.
World J Gastroenterol. Feb 28, 2009; 15(8): 942-954
Published online Feb 28, 2009. doi: 10.3748/wjg.15.942
Table 2 Comparative overview of the primary parameters at inclusion versus end-of-treatment in study groups and in overall patients
UnitsOverall
Group T
Group V
mean ± SEPmean ± SEPmean ± SEP
sBP (V1)mmHg156.54 ± 1.28< 0.0001155.71 ± 1.61< 0.0001157.42 ± 2.04< 0.0001
sBP (V6)134.24 ± 1.28133.21 ± 1.23135.35 ± 2.31
dBP (V1)mmHg101.65 ± 1.05< 0.0001101.43 ± 1.17< 0.0001101.89 ± 1.8< 0.0001
dBP (V6)77.8 ± 1.0477.14 ± 1.2578.5 ± 1.7
ALT (V1)IU/L67.65 ± 2.01< 0.00166.96 ± 2.95< 0.00168.38 ± 2.75< 0.001
ALT (V6)49.48 ± 1.1646.68 ± 1.4252.50 ± 1.70
AST (V1)IU/L70.31 ± 2.34< 0.00172.78 ± 3.53< 0.00167.65 ± 3.02< 0.001
AST (V6)51.11 ± 1.8347.57 ± 2.0854.92 ± 2.95
GGT (V1)IU/L23.85 ± 1.62NS22.60 ± 2.37NS25.19 ± 2.22NS
GGT (V6)21.02 ± 1.9821.96 ± 3.5520 ± 1.58
B (V1)mg/dL0.89 ± 0.02NS0.9 ± 0.03NS0.88 ± 0.04NS
B (V6)0.94 ± 0.020.94 ± 0.030.93 ± 0.03
BMI (V1)kg/m227.42 ± 0.36NS27.21 ± 0.51NS27.65 ± 0.53NS
BMI (V6)26.96 ± 0.3626.93 ± 0.4927.00 ± 0.54
HOMA-IR (V1)mg ×&mgr;IU7.7 ± 0.24< 0.0017.81 ± 0.40< 0.0017.57 ± 0.25< 0.05
HOMA-IR (V6)/dL × 10-25.19 ± 0.184.48 ± 0.215.95 ± 0.22
TG (V1)mg/dL161.51 ± 4.98< 0.051165.64 ± 6.95< 0.0311157.08 ± 7.18NS1
F: 168.42 ± 8.28F: 169.85 ± 11.2F: 166.75 ± 12.82
M: 155.10 ± 5.63M:161.42 ± 8.49M: 148.78 ± 7.31
TG (V6)153.96 ± 4.8154.14 ± 6.79153.77 ± 6.93
F: 160 ± 8.29F: 156.78 ± 11.33F: 163.75 ± 12.61
M: 148.35 ± 5.09M: 151.5 ± 7.88M: 145.21 ± 6.65
TC (V1)mg/dL196.46 ± 1.13< 0.0081196.07 ± 1.5< 0.0241196.88 ± 1.73NS1
F: 191.77 ± 1.5M: 200.57 ± 1.29M: 201.07 ± 2.07
M: 200.82 ± 1.2F: 191.57 ± 2.13F: 192 ± 2.19
TC (V6)194.04 ± 1.19191.89 ± 1.64196.35 ± 1.64
F: 189.73 ± 1.58F: 188 ± 2.23F: 191.75 ± 2.19
M: 198.04 ± 1.39M: 195.79 ± 1.96M: 200.29 ± 1.87
NAS (V1)Point5.89 ± 0.14< 0.00116 ± 0.18< 0.04515.77 ± 0.22NS1
Steatosis2.16 ± 0.092Excepting inflammation (V1) vs (V6)2.21 ± 0.122.11 ± 0.162Excepting steatosis (V1) vs (V6) P = 0.027
Inflammation1.70 ± 0.06NS1.68 ± 0.091.73 ± 0.09
Balooning2.02 ± 0.12.11 ± 0.131.92 ± 0.16
NAS (V6)4.96 ± 0.144.57 ± 0.185.38 ± 0.2
Steatosis1.74 ± 0.091.71 ± 0.111.77 ± 0.15
Inflammation1.55 ± 0.101.32 ± 0.121.81 ± 0.14
Balooning1.67 ± 0.081.53 ± 0.111.81 ± 0.13
Fibrosis (V1)Point2.11 ± 0.11< 0.0012.07 ± 0.16< 0.0012.15 ± 0.15NS
Fibrosis (V6)1.57 ± 0.091.32 ± 0.131.84 ± 0.11